These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 30592286)
21. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer. Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator. Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250 [TBL] [Abstract][Full Text] [Related]
23. Long Non-coding RNA MALAT1 Upregulates ZEB2 Expression to Promote Malignant Progression of Glioma by Attenuating miR-124. Cheng H; Zhao H; Xiao X; Huang Q; Zeng W; Tian B; Ma T; Lu D; Jin Y; Li Y Mol Neurobiol; 2021 Mar; 58(3):1006-1016. PubMed ID: 33078370 [TBL] [Abstract][Full Text] [Related]
24. KLF5 regulates epithelial-mesenchymal transition of liver cancer cells in the context of p53 loss through miR-192 targeting of ZEB2. Sun L; Zhou X; Li Y; Chen W; Wu S; Zhang B; Yao J; Xu A Cell Adh Migr; 2020 Dec; 14(1):182-194. PubMed ID: 32965165 [TBL] [Abstract][Full Text] [Related]
25. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma. Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263 [TBL] [Abstract][Full Text] [Related]
26. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
29. MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2. Huang L; Liu Z; Hu J; Luo Z; Zhang C; Wang L; Wang Z Pharmacol Res; 2020 Jun; 156():104774. PubMed ID: 32220639 [TBL] [Abstract][Full Text] [Related]
30. Hypoxia-inducible factor 3α1 increases epithelial-to-mesenchymal transition and iron uptake to drive colorectal cancer liver metastasis. Villareal LB; Falcon DM; Xie L; Xue X Br J Cancer; 2024 Jun; 130(12):1904-1915. PubMed ID: 38693428 [TBL] [Abstract][Full Text] [Related]
31. MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2. Gao HB; Gao FZ; Chen XF Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5149-5157. PubMed ID: 31298368 [TBL] [Abstract][Full Text] [Related]
32. miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Pang X; Huang K; Zhang Q; Zhang Y; Niu J Oncol Rep; 2015 Dec; 34(6):3272-9. PubMed ID: 26503460 [TBL] [Abstract][Full Text] [Related]
33. Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B. Hu M; Wang M; Lu H; Wang X; Fang X; Wang J; Ma C; Chen X; Xia H Oncotarget; 2016 Jul; 7(28):43419-43431. PubMed ID: 27270326 [TBL] [Abstract][Full Text] [Related]
34. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer. Gong P; Qiao F; Wu H; Cui H; Li Y; Zheng Y; Zhou M; Fan H Cell Death Dis; 2018 Nov; 9(12):1158. PubMed ID: 30464170 [TBL] [Abstract][Full Text] [Related]
35. A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma. Jiang Q; Zhou Y; Yang H; Li L; Deng X; Cheng C; Xie Y; Luo X; Fang W; Liu Z Oncotarget; 2016 Oct; 7(41):67288-67301. PubMed ID: 27589832 [TBL] [Abstract][Full Text] [Related]
36. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling. Hu X; Wang R; Ren Z; Liu X; Gu J; Cui G; Li Q Cancer Med; 2019 Dec; 8(17):7359-7371. PubMed ID: 31637871 [TBL] [Abstract][Full Text] [Related]
37. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
39. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway. Sun L; Guo Z; Sun J; Li J; Dong Z; Zhang Y; Chen J; Kan Q; Yu Z Biomed Pharmacother; 2018 Nov; 107():168-176. PubMed ID: 30086463 [TBL] [Abstract][Full Text] [Related]
40. The Long Noncoding RNA ZEB2-AS1 Contributes to Proliferation and Epithelial-to-Mesenchymal Transition of Osteosarcoma. Yang J; Zou Y; Wu J; Chen B; Luo C; Chen X; Shen H; Luo L Cancer Biother Radiopharm; 2023 Nov; 38(9):596-603. PubMed ID: 33085924 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]